The #1 Community for Investors
Results 71 - 80 of 4004 : Previous 4 5 6 7 8 9 10 11 12 Next
3 More Stock-Moving Binary Events to Watch in 2012
A quick look at some drugs waiting for review.
Breaking down the market.
Profit From These Special Situations
Unlock the value hidden in spinoffs, mergers, acquisitions, and restructurings.
A Bad Year for the 6,300% Miracle
Human Genome Sciences falls from grace.
What to Look For With Seattle Genetics in 2012
The launch of its new drug Adcetris will be key.
Whoa! These Stocks Stood the Market on Its Ear
These stocks just took off, but are they about to make a return trip to Earth?
What to Look For From Keryx and Aeterna Zentaris in 2012
The future is uncertain for these pharmaceutical companies.
Abbott Labs: Dividend Dynamo or the Next Blowup?
What the numbers tell us.
5-Star Stocks Poised to Pop: Novartis
Market-trouncing returns could be written in this five-star.
Results 71 - 80 of 4004 : Previous 4 5 6 7 8 9 10 11 12 Next
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK